JP2025503512A5 - - Google Patents

Info

Publication number
JP2025503512A5
JP2025503512A5 JP2024538656A JP2024538656A JP2025503512A5 JP 2025503512 A5 JP2025503512 A5 JP 2025503512A5 JP 2024538656 A JP2024538656 A JP 2024538656A JP 2024538656 A JP2024538656 A JP 2024538656A JP 2025503512 A5 JP2025503512 A5 JP 2025503512A5
Authority
JP
Japan
Prior art keywords
conjugate according
uaa
residue
targeting domain
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538656A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503512A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/082277 external-priority patent/WO2023122753A1/en
Publication of JP2025503512A publication Critical patent/JP2025503512A/ja
Publication of JP2025503512A5 publication Critical patent/JP2025503512A5/ja
Pending legal-status Critical Current

Links

JP2024538656A 2021-12-22 2022-12-22 架橋抗体 Pending JP2025503512A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163293025P 2021-12-22 2021-12-22
US63/293,025 2021-12-22
US202263346799P 2022-05-27 2022-05-27
US63/346,799 2022-05-27
US202263388072P 2022-07-11 2022-07-11
US63/388,072 2022-07-11
PCT/US2022/082277 WO2023122753A1 (en) 2021-12-22 2022-12-22 Crosslinking antibodies

Publications (2)

Publication Number Publication Date
JP2025503512A JP2025503512A (ja) 2025-02-04
JP2025503512A5 true JP2025503512A5 (https=) 2025-12-26

Family

ID=86903805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538656A Pending JP2025503512A (ja) 2021-12-22 2022-12-22 架橋抗体

Country Status (6)

Country Link
EP (1) EP4452333A1 (https=)
JP (1) JP2025503512A (https=)
KR (1) KR20240139054A (https=)
AU (1) AU2022419596A1 (https=)
CA (1) CA3241897A1 (https=)
WO (1) WO2023122753A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022232377A2 (en) * 2021-04-28 2022-11-03 The Regents Of The University Of California Bioreactive proteins containing unnatural amino acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019231893B2 (en) * 2018-03-08 2024-07-18 The Regents Of The University Of California Bioreactive compositions and methods of use thereof
WO2020206341A1 (en) * 2019-04-04 2020-10-08 The Regents Of The University Of California Method to generate biochemically reactive amino acids
WO2021102624A1 (en) * 2019-11-25 2021-06-03 Hangzhou Branch Of Technical Institute Of Physics And Chemistry, Chinese Academy Of Sciences Covalent protein drugs developed via proximity-enabled reactive therapeutics (perx)
CN112028987B (zh) * 2020-06-01 2021-07-30 广东圣赛生物科技有限公司 一种结合免疫抑制分子pd-l1的蛋白药物
WO2022187273A1 (en) * 2021-03-01 2022-09-09 The Regents Of The University Of California Bioreactive compounds and methods of use thereof
WO2022194078A1 (zh) * 2021-03-15 2022-09-22 北京大学 用于靶分子修饰的缀合物及其制备方法
WO2022232377A2 (en) * 2021-04-28 2022-11-03 The Regents Of The University Of California Bioreactive proteins containing unnatural amino acids

Similar Documents

Publication Publication Date Title
US12384835B2 (en) Cysteine linked nanobody dimers
JP2021121590A5 (https=)
JP2021531826A5 (https=)
JP2019536740A5 (https=)
JP2021113191A5 (https=)
JP2023512036A5 (https=)
JP2022541517A5 (https=)
JP6714687B2 (ja) 抗体薬物複合体における共有結合リンカー、並びにその製造方法及び使用方法
RU2019129839A (ru) Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты
JP7815223B2 (ja) 可溶性タグを有する分子および関連方法
JP2022530089A5 (https=)
JP2023078174A5 (https=)
US11021544B2 (en) Nanobody dimers linked via C-terminally engineered cysteins
JP2024149655A5 (https=)
JP2022520260A (ja) 改善された均一性を有する抗体薬物コンジュゲートの調製するプロセス
JP2018058902A5 (https=)
JP2025026839A5 (https=)
CN107614488B (zh) 新型亲水连接体和其在配体-药物共轭偶联物上的应用
JP2023519776A5 (https=)
JP2025023920A5 (https=)
JP2022514786A5 (https=)
EA200602183A1 (ru) Биспецифичные гибридные антитела с увеличенным периодом полувыведения из сыворотки
JP2011092194A5 (https=)
JP2023515941A5 (https=)
JP2025509286A5 (https=)